Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » Revolade 50 mg (Eltrombopag Olamine)
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info

Revolade 50 mg (Eltrombopag Olamine)

MBA Pharmaceuticals Pvt Ltd
Category: 
Pharma & Supplements
Drugs

Manufacturer: Glaxo SmithKline Pharmaceuticals Ltd

Medicine composition: Eltrombopag Olamine

Revolade 50Mg Tablet belongs to a class of drugs called thrombopoietin (TPO) receptor agonists, and is used to treat patients who have low platelet counts as a result of chronic immune thrombocytopenia or chronic hepatitis C virus infection. Revolade 50Mg Tablet is also used in combination with other drugs to treat conditions such as severe aplastic anemia. Generally, this medicine is administered to those patients who have not responded very well to other medicines, or surgery.

Revolade 50Mg Tablet is administered in the form of oral tablets, or via suspension, both of which are taken by the mouth, according to the dosage prescribed by the doctor.

Features:

  • Longer shelf life
  • Precise formulation
  • Effective results
Specialty: 
Hematology
View this product at mbapharmaceuticals.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree